P1NP (Procollagen Type 1 N-Propeptide)
P1NP (Procollagen Type 1 N-Propeptide) is a number a lab report prints. What it measures, in the Library's words: DEXA (dual-energy X-ray absorptiometry) measures bone mineral density and reports it as a T-score (standard deviations from a young healthy adult reference). No single unit is recorded for it on its own; the range note on this page prints the units its entry uses. It is read on the Perimenopause & Menopause panel.
What it measures
DEXA (dual-energy X-ray absorptiometry) measures bone mineral density and reports it as a T-score (standard deviations from a young healthy adult reference). CTX (C-terminal telopeptide) is a marker of bone *resorption* (breakdown), and P1NP (procollagen type 1 N-terminal propeptide) is a marker of bone *formation* -- together, "bone turnover markers." All three matter here because bone remodeling accelerates sharply at menopause: falling estrogen removes a brake on osteoclast (bone-resorbing) activity, and resorption temporarily outpaces formation, driving the fastest bone loss of a woman's life in the first 5-10 years after the final period.
Also printed on lab reports as: p1np; pinp; procollagen type 1 n terminal propeptide; procollagen type i n terminal propeptide; total p1np.
Filed under: Hormones & Fertility.
Range and unit
No single unit is recorded for this marker on its own. The range note below prints the units its entry uses, and your report's own unit comes first.
How the entry records the range: DEXA T-score: -1.0 to +1.0 normal, -1.0 to -2.5 osteopenia, ≤-2.5 osteoporosis (WHO diagnostic criteria). CTX and P1NP have assay-specific reference ranges and are not used to diagnose osteoporosis -- their main validated clinical use is monitoring response to osteoporosis treatment (a good antiresorptive response shows CTX dropping substantially within 3-6 months; anabolic treatment shows P1NP rising). The International Osteoporosis Foundation and International Federation of Clinical Chemistry specifically recommend serum P1NP and CTX as the reference markers for this monitoring role. (source: Vasikaran S et al., IOF-IFCC bone turnover marker position paper, Osteoporosis International, 2011, PMID 21184054; Bone Turnover Markers: Basic Biology to Clinical Applications, Endocrine Reviews, 2023)
A range is a reference with a history, never a verdict. Measurement science, not a diagnosis. Your clinician has the last word.
Where it is read
The Library reads P1NP (Procollagen Type 1 N-Propeptide) on this panel.
Open P1NP (Procollagen Type 1 N-Propeptide) in the Library, with the studies underneath
Also read on the Perimenopause & Menopause panel
What moves it
A lab number moves with its cofactors, not on its own. These are shown as a set, in alphabetical order; a count is how much has been read, never how strong. Each study id opens the paper the Library records.
Needed to use it, or raises it
Read alongside it
- Iron · named together in 52 studiesHH-89819HH-112838HH-165382
- Phosphorus · named together in 202 studiesHH-0069HH-12964HH-14780
- Potassium · named together in 59 studiesHH-3049HH-104512HH-135980
- Sodium · named together in 67 studiesHH-3049HH-3795HH-84109
- Zinc · named together in 80 studiesHH-12148HH-19236HH-19237
Competes with it, draws it down, or moves it down
Tests a routine panel leaves out
For some of these nutrients the map names a test that a routine blood count, metabolic panel, lipid panel and TSH do not carry: Ferritin and iron studies, Magnesium (red-cell), Vitamin D (25-hydroxy) and Zinc. How to get measured lists where each can be ordered.
The 31 studies behind these rows
- HH-0069Effects of boron supplementation on bone mineral density and dietary blood and urinary calcium phosphorus magnesium and boron in female athletes (1994)
- HH-104512Delay of natural bone loss by higher intakes of specific minerals and vitamins (2001)
- HH-104580[Vitamin K2] (2008)
- HH-104600The Dual Role of Vitamin K2 in “Bone-Vascular Crosstalk”: Opposite Effects on Bone Loss and Vascular Calcification (2021)
- HH-112838Diet and growth of vegetarian and vegan children (2023)
- HH-12148Effects of zinc carnosine on bone loss in mice with diabetic osteoporosis. (2026)
- HH-12365Vitamin D and Fracture Healing. (2026)
- HH-12964Phosphate homeostasis disorders. (2018)
- HH-135980No evidence that the skeletal non-response to potassium alkali supplements in healthy postmenopausal women depends on blood pressure or sodium chloride intake (2012)
- HH-14780Phosphatonins: From Discovery to Therapeutics. (2023)
- HH-165382Impact of breastfeeding on serological recovery and metabolic homeostasis in postpartum women with celiac disease: a longitudinal study (2026)
- HH-180333Effect of Low-Dose Vitamin K2 Supplementation on Bone Mineral Density in Middle-Aged and Elderly Chinese: A Randomized Controlled Study (2020)
- HH-18455Role of calcium and vitamin D in the prevention and the treatment of postmenopausal osteoporosis: an overview. (1995)
- HH-18549Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. (1995)
- HH-18578Magnesium supplementation and osteoporosis. (1995)
- HH-18584Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. (1993)
- HH-18591Calcium supplementation increases bone density in adolescent girls. (1994)
- HH-19236Role of nutritional zinc in the prevention of osteoporosis (2010)
- HH-19237Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial (2013)
- HH-291868A COMPARATIVE STUDY OF EFFICACY OF CALCIUM + VITAMIN D3 AND CALCIUM + VITAMIN D3 + VITAMIN K2 IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL OSTEOPENIC WOMEN WHO ARE ADOPTING A SEDENTARY PATTERN OF LIFE STYLE (2013)
- HH-3049Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial (2020)
- HH-376007Calcium and vitamin D in the management of osteoporosis (2021)
- HH-3795Lithium and lithium carbonate prescribing information (2018)
- HH-459191Methotrexate Chemotherapy Causes Growth Impairments, Vitamin D Deficiency, Bone Loss, and Altered Intestinal Metabolism—Effects of Calcitriol Supplementation (2023)
- HH-46636Effect of vitamin D on the intestinal absorption of 203Pb and 47Ca in chicks (1982)
- HH-501142The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney Disease (2018)
- HH-501187The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study (2013)
- HH-5414The effect of calcium supplementation in people under 35 years old: A systematic review and meta-analysis of randomized controlled trials (2022)
- HH-5903Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial (1995)
- HH-84109Naringin protects against bone loss in steroid-treated inflammatory bowel disease in a rat model (2018)
- HH-89819Bone abnormalities in young male rats with iron intervention and possible mechanisms (2018)
Studies that name it
233 approved studies in the library name P1NP (Procollagen Type 1 N-Propeptide). 39 of them are recorded as a trial, an observational study or a pooled analysis; most rows record no design.
The 8 below are listed in this order: studies that name it in the title, then recorded trials, observational studies and pooled analyses, then the newest.
- Bone Turnover Markers (CTX and P1NP) Following Low-Carbohydrate and Mediterranean Diet Interventions in Adolescents and Young Adults with Type 1 Diabetes (2025) · HH-180234 · trial, observational study or pooled analysis
- Association between fibrinogen-to-albumin ratio and bone metabolism markers (β-CTX and P1NP) in Chinese individuals with osteoporotic fracture: a cross-sectional investigation (2025) · HH-501063 · trial, observational study or pooled analysis
- The Influence of Nutrition Intervention on the P1NP and CTX-1 Response to an Acute Exercise Bout: A Systematic Review with Meta-Analysis (2024) · HH-643008 · trial, observational study or pooled analysis
- Reference intervals for plasma β-CTX and P1NP in children: A systematic review and pooled estimates (2023) · HH-240030 · trial, observational study or pooled analysis
- Dimethandrolone Undecanoate, a Novel, Nonaromatizable Androgen, Increases P1NP in Healthy Men Over 28 Days (2020) · HH-501080 · trial, observational study or pooled analysis
- Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus (2020) · HH-501125 · trial, observational study or pooled analysis
- Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial (2019) · HH-637723 · trial, observational study or pooled analysis
- Lower-serum P1NP/βCTX ratio and hypoalbuminemia are independently associated with osteoporotic nonvertebral fractures in older adults (2017) · HH-731529 · trial, observational study or pooled analysis
Counted on 2026-11-22 across 923,626 approved studies: a study is counted when its title or its one-line takeaway names the marker. A count is where the library has been pointed, never a verdict on the field. Open P1NP (Procollagen Type 1 N-Propeptide) in the Library
Foods that move it
The food matrix ties a food to a marker in two ways, and they are kept apart. A food leading with a nutrient is a measurement of the food, not a promise about a result.
Through the nutrients they lead with
For the nutrients above that the library ties to this marker by a named relation, these are the foods the matrix lists as leading with each one (the most per 100 g first, from USDA), and the ingredient brief where one exists.
Calcium
5 of 18 foods shown. Read the Calcium brief
Magnesium
5 of 23 foods shown. Read the Magnesium brief
Vitamin D
Vitamin K
5 of 6 foods shown. Read the Vitamin K brief
Concerns that name it
A concern is a question, not a diagnosis. These concern pages either list this marker among the numbers the Library ties to them, or send you to a panel that reads it.
Enter your numbers
Type in the value from a report you already have, or import the report, and each one is read against the evidence. Your lab values stay on your device. They are never uploaded to The Lab Atlas.
All markers · Questions people ask · Questions: info@thelabatlas.org